Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the rt_theme domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/u130574652/domains/nextlabs.co.in/public_html/wp-includes/functions.php on line 6114
VEROGO-16/24 (Betahistine-16/24 mg) – Next Labs
  1. Home
  2. Our Products
  3. VEROGO-16/24 (Betahistine-16/24 mg)

VEROGO-16/24 (Betahistine-16/24 mg)

DESCRIPTION

Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière’s disease. It is also commonly used for patients with balance disorders.

SIDE EFFECTS

The signs and symptoms that are produced after the acute overdosage of Betahistine (HCl) include Nausea, Vomiting, Seizures, Dyspepsia, Ataxia.

The symptomatic adverse reactions produced by Betahistine (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Drowsiness, Nausea, Dyspepsia.

INDICATIONS

Ménière’s syndrome as defined by the following core symptoms:

  • vertigo (with nausea/vomiting)
  • hearing loss (hardness of hearing)
  • tinnitus

AVAILABILITY

VEROGO is available in strips  of  ten  capsules containing VEROGO Capsules.

About us

NEXT LABS, a name that that signifies the state of well-being is dedicated to promoting healthcare for more than a decade and provides high quality products for customers focused on healthcare and diseases. Since its inception, NEXT has been on a quest to sustain and improve the quality of life with the ultimate purpose of making the world a healthier place.